The market size for Synthetic Stem Cells is expected to grow from USD 14 million in 2023 to USD 37 million by 2028, at a CAGR of 22.5% during the forecast period. The study involved four major activities in estimating the current market size for synthetic stem cells. Exhaustive secondary research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. The top-down approach was employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the size of the segments and subsegments of the market.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=4959435

Key Market Players

The technology is developed and patented by North Carolina State University (NCSU) (US) and Zhengzhou University (China)

The cardiovascular diseases segment is expected to command the largest share of the overall synthetic stem cells market during the forecast period.

The synthetic stem cells market, by application, is estimated to be dominated by the cardiovascular diseases segment in 2023. This is attributed to the fact that the synthetic stem cells have been firstly developed for cardiac tissue and are tested in mice models. After the successful pre-clinical testing of cardiac synthetic stem cells, these cells will enter the clinical phase of development and are expected to hit the market by 2023.

By application, the cardiovascular diseases segment accounted for the largest share during the forecast period.

The major applications of synthetic stem cells include cardiovascular diseases, neurological disorders, and other diseases that require regenerative therapy. Cardiovascular diseases have high prevalence across the globe. Currently, synthetic mesenchymal cells have been developed only for cardiac tissue and have been tested in mice models. The research on cardiac synthetic stem cells is expected to enter the clinical phase in the coming 2-3 years, and the first commercial product would be cardiac synthetic stem cells in the next five years.

Request Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=4959435

North America to lead the synthetic stem cells market with accelerated RD activities in stem cell therapy research.

North America is estimated to account for the largest share of the market in 2023. North America is the pioneer of synthetic stem cell technology. Also, North America leads in the RD of stem cell therapies globally, with the registration of the highest number of clinical trials (more than 1400) on stem cells till 2018. This is further backed by the high rate of adoption of advanced therapies in the US (more than 600 stem cell therapy clinics in the US in 2016).

Market Dynamics

Market Drivers

• Ethical Concerns Regarding Embryonic Stem Cells
• Risk of Tumor Formation and Immune Rejection of Natural Stem Cells

 Market Restraints

• Unclear and Unstructured Regulations

 Market Opportunities

• Costly Storage and Fragility of Natural Stem Cells
• Potential Application in Major Indications
• Increasing Stem Cell Research Funding

Key questions addressed by the report:

• What is synthetic stem cell technology?
• What could be the future of this technology in the coming years?
• What are the regional growth trends and the largest revenue-generating regions for synthetic stem cells?
• What are the major applications of synthetic stem cells?

Get 10% Free Customization on this Report:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=4959435

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

Email: [email protected]

https://www.marketsandmarkets.com/PressReleases/synthetic-stem-cells.asp